Literature DB >> 19201830

Cutting edge: Phenotypic characterization and differentiation of human CD8+ T cells producing IL-17.

Takaaki Kondo1, Hiroshi Takata, Fumichika Matsuki, Masafumi Takiguchi.   

Abstract

Although IL-17-producing CD8(+) T cells (Tc17 cells) have recently been identified, the detailed information about these cells still remains unclear. In this article we describe a study investigating the phenotype and differentiation of human Tc17 cells. Human Tc17 cells were detected in a minor population of CD8(+) T cells and were predominantly found in CD27(-/+)CD28(+)CD45RA(-) memory subsets. They also expressed CCR6 and a high level of CCR5. Though most Tc17 cells produced IFN-gamma, a small part of the Tc17 cell population was IFN-gamma negative in some individuals. Analysis of the in vitro induction of Tc17 cells showed that these cells were induced from the CD27(+)CD28(+)CD45RA(+) naive subset and that they expressed the CD27(-)CD28(+)CD45RA(-) and CCR6(+) phenotype. These results together indicate that Tc17 cells have a unique phenotype and suggest that they differentiate from the same precursors that differentiate into IFN-gamma-producing CD8(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19201830     DOI: 10.4049/jimmunol.0801347

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  75 in total

1.  Inflammatory cytokines determine the susceptibility of human CD8 T cells to Fas-mediated activation-induced cell death through modulation of FasL and c-FLIP(S) expression.

Authors:  Anna von Rossum; Randall Krall; Nichole K Escalante; Jonathan C Choy
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

2.  Adoptive transfer of tumor-specific Tc17 effector T cells controls the growth of B16 melanoma in mice.

Authors:  Maria de la Luz Garcia-Hernandez; Hiromasa Hamada; Joyce B Reome; Sara K Misra; Michael P Tighe; Richard W Dutton
Journal:  J Immunol       Date:  2010-03-17       Impact factor: 5.422

3.  Secretion of interleukin-17 by CD8+ T cells expressing CD146 (MCAM).

Authors:  Pradeep K Dagur; Angélique Biancotto; Elena Stansky; H Nida Sen; Robert B Nussenblatt; J Philip McCoy
Journal:  Clin Immunol       Date:  2014-02-13       Impact factor: 3.969

Review 4.  Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells.

Authors:  Min S Shin; Naeun Lee; Insoo Kang
Journal:  Curr Opin Rheumatol       Date:  2011-09       Impact factor: 5.006

5.  Cytokine requirements for the differentiation and expansion of IL-17A- and IL-22-producing human Vgamma2Vdelta2 T cells.

Authors:  Kristin J Ness-Schwickerath; Chenggang Jin; Craig T Morita
Journal:  J Immunol       Date:  2010-05-14       Impact factor: 5.422

Review 6.  Regulation and function of IL-17A- and IL-22-producing γδ T cells.

Authors:  Kristin J Ness-Schwickerath; Craig T Morita
Journal:  Cell Mol Life Sci       Date:  2011-05-15       Impact factor: 9.261

7.  IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis.

Authors:  Magdalena Huber; Sylvia Heink; Axel Pagenstecher; Katharina Reinhard; Josephine Ritter; Alexander Visekruna; Anna Guralnik; Nadine Bollig; Katharina Jeltsch; Christina Heinemann; Eva Wittmann; Thorsten Buch; Olivia Prazeres da Costa; Anne Brüstle; Dirk Brenner; Tak W Mak; Hans-Willi Mittrücker; Björn Tackenberg; Thomas Kamradt; Michael Lohoff
Journal:  J Clin Invest       Date:  2012-12-10       Impact factor: 14.808

8.  Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus.

Authors:  Kamini Shah; Won-Woo Lee; Seung-Hyun Lee; Sang Hyun Kim; Seong Wook Kang; Joe Craft; Insoo Kang
Journal:  Arthritis Res Ther       Date:  2010-03-24       Impact factor: 5.156

9.  Human Th17 cells can be induced through head and neck cancer and have a functional impact on HNSCC development.

Authors:  R Kesselring; A Thiel; R Pries; T Trenkle; B Wollenberg
Journal:  Br J Cancer       Date:  2010-09-28       Impact factor: 7.640

10.  Cholera toxin enhances interleukin-17A production in both CD4+ and CD8+ cells via a cAMP/protein kinase A-mediated interleukin-17A promoter activation.

Authors:  Hsing-Chuan Tsai; Sharlene Velichko; Shanshan Lee; Reen Wu
Journal:  Immunology       Date:  2018-02-20       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.